Clinical Trials · NCT00004993

Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis

CompletedPhase 2Teriparatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment
0
Start date
Aug 1999
Locations
1 site, United States
Primary endpoint
Study in Osteoporosis
View Teriparatide compound reference